These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25955097)

  • 1. Prognostic implications of thymidylate synthase gene polymorphisms in patients with advanced small bowel adenocarcinoma treated with first-line fluoropyrimidine-based chemotherapy.
    Yhim HY; Cho SH; Kim SY; Cho IS; Lee KT; Lee WS; Lee SI; Park MR; Park SG; Han HS; Choi YS; Chung IJ; Shim HJ; Lee NR; Song EK; Kim HS; Yim CY
    Oncol Rep; 2015 Jul; 34(1):155-64. PubMed ID: 25955097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.
    Hur H; Kang J; Kim NK; Min BS; Lee KY; Shin SJ; Keum KC; Choi J; Kim H; Choi SH; Lee MY
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):669-76. PubMed ID: 20932673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
    Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
    Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
    Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
    Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M
    Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancer.
    Ott K; Vogelsang H; Marton N; Becker K; Lordick F; Kobl M; Schuhmacher C; Novotny A; Mueller J; Fink U; Ulm K; Siewert JR; Höfler H; Keller G
    Int J Cancer; 2006 Dec; 119(12):2885-94. PubMed ID: 16929515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients.
    Kuramochi H; Tanaka K; Oh D; Lehman BJ; Dunst CM; Yang DY; De Meester SR; Hagen JA; Danenberg KD; De Meester TR; Danenberg PV
    Int J Oncol; 2008 Jan; 32(1):201-8. PubMed ID: 18097560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
    Powrózek T; Kowalski DM; Krawczyk P; Ramlau R; Kucharczyk T; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Dyszkiewicz W; Krzakowski M; Milanowski J
    Clin Lung Cancer; 2014 Nov; 15(6):455-65. PubMed ID: 25246386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
    Huang ZH; Hua D; Li LH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the polymorphisms of thymidylate synthase on cell-free circulating DNA in blood of patients with advanced colorectal carcinoma.
    Schwarzenbach H; Goekkurt E; Pantel K; Aust DE; Stoehlmacher J
    Int J Cancer; 2010 Aug; 127(4):881-8. PubMed ID: 19998340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.
    Kawakami K; Graziano F; Watanabe G; Ruzzo A; Santini D; Catalano V; Bisonni R; Arduini F; Bearzi I; Cascinu S; Muretto P; Perrone G; Rabitti C; Giustini L; Tonini G; Pizzagalli F; Magnani M
    Clin Cancer Res; 2005 May; 11(10):3778-83. PubMed ID: 15897576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.
    Meulendijks D; Jacobs BA; Aliev A; Pluim D; van Werkhoven E; Deenen MJ; Beijnen JH; Cats A; Schellens JH
    Int J Cancer; 2016 Jan; 138(1):245-53. PubMed ID: 26189437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.
    Kawakami K; Watanabe G
    Cancer Res; 2003 Sep; 63(18):6004-7. PubMed ID: 14522928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.
    Goekkurt E; Hoehn S; Wolschke C; Wittmer C; Stueber C; Hossfeld DK; Stoehlmacher J
    Br J Cancer; 2006 Jan; 94(2):281-6. PubMed ID: 16317430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidylate synthase gene polymorphism predicts disease free survival in stage II-III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy.
    Su X; Li S; Zhang H; Xiao H; Chen C; Wang G
    Chin Clin Oncol; 2019 Jun; 8(3):28. PubMed ID: 30823845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
    Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5-flurouracil-based chemotherapy.
    Park CM; Lee WY; Chun HK; Cho YB; Yun HR; Heo JS; Yun SH; Kim HC
    J Surg Oncol; 2010 Jan; 101(1):22-7. PubMed ID: 19798689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.
    Stoehlmacher J; Goekkurt E; Mogck U; Aust DE; Kramer M; Baretton GB; Liersch T; Ehninger G; Jakob C
    Cancer Lett; 2008 Dec; 272(2):221-5. PubMed ID: 18722050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Arrazubi V; Suárez J; Guerrero D; Gómez M; Viúdez A; Arias F; Balén E; Vera R
    Colorectal Dis; 2013 Apr; 15(4):428-35. PubMed ID: 22958523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.
    Kucharczyk T; Krawczyk P; Powrózek T; Kowalski DM; Ramlau R; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Krzakowski M; Milanowski J
    Pathol Oncol Res; 2016 Jan; 22(1):49-56. PubMed ID: 26277606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.